Close Menu

NEW YORK (GenomeWeb) – Biocept has filed a shelf registration to offer from time to time up to $50 million of its securities. 

In a document filed with the US Securities and Exchange Commission on Thursday, the company said that the form of securities to be offered may comprise common stock, preferred stock, debt securities, and warrants. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.